Delisting riskPopularity #5,231
N2OFF (NXTS)
Develops mitochondrial transporter drug candidates and European solar and storage projects.
$1.40
After-hours close−0.03 (−2.10%)
At close$1.43(+3.62%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 4.36% | 63.4K shares | |
|---|---|---|---|
| 6 holders · as of Jun 30, 2026 | |||
| Insiders | 4.71% | 68.5K shares | |
| 1 holder · as of Mar 26, 2026 | |||
| Other | 90.93% | 1.32M shares | |
| remainder | |||
1.45M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (1.45M in the company's Sep 23, 2026 report, 56.6K elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
13F, as of Jun 30, 2026
6 holders · 63.4K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| HRT Financial LP | 45.2K | 3.11% | Aug 14, 2026 | |
| Yorkville Advisors Global, LP | 16.4K | 1.13% | Aug 6, 2026 | |
| Vanguard Fiduciary Trust Co | 998 | 0.07% | Aug 13, 2026 | |
| Tower Research Capital LLC (TRC) | 736 | 0.05% | Aug 11, 2026 | |
| Sbi Securities Co., Ltd. | 32 | 0.00% | Jul 23, 2026 | |
| Barclays PLC | 1 | 0.00% | Aug 14, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 29, 2026 | Eun Young Lee10 percent owner | Sale | 127 | $1.36 | 479,524 |
House and Senate disclosures
Not reported.